Prosthetic Valve Dysfunction 35 Years after Mitral Valve Replacement with a Starr-Edwards Caged-disc Valve
Tetsuro Yokokawa(Fukushima Medical University), Toshihisa Anzai(Hokkaido University), Seiji Takashio(Kumamoto University), Satoshi Yasuda(Tohoku University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Takuya Hasegawa(Tokyo Institute of Technology), Mari Sakamoto(National Cerebral and Cardiovascular Center), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Tomoyuki Fujita(The University of Tokyo), Makoto Amaki(National Cerebral and Cardiovascular Center), Yuko Wada(Shiga University of Medical Science), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Yoko Okamoto(Juntendo University), Kenji Nakamura(Ise Red Cross Hospital), Junjiro Kobayashi(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Taka-aki Matsuyama(National Cerebral and Cardiovascular Center), Yasuo Sugano(keiyu Hospital)
Cited by 1
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755